Allianz Asset Management GmbH Increases Stake in Sabra Healthcare REIT, Inc. $SBRA

Allianz Asset Management GmbH grew its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 9.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 902,998 shares of the real estate investment trust’s stock after purchasing an additional 81,293 shares during the quarter. Allianz Asset Management GmbH’s holdings in Sabra Healthcare REIT were worth $16,832,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the business. Covestor Ltd raised its holdings in Sabra Healthcare REIT by 23,720.0% in the 3rd quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust’s stock valued at $45,000 after acquiring an additional 2,372 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in shares of Sabra Healthcare REIT by 150.7% in the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after purchasing an additional 1,536 shares in the last quarter. Farther Finance Advisors LLC increased its holdings in shares of Sabra Healthcare REIT by 685.7% in the third quarter. Farther Finance Advisors LLC now owns 3,952 shares of the real estate investment trust’s stock valued at $74,000 after purchasing an additional 3,449 shares during the last quarter. Ameritas Advisory Services LLC purchased a new position in Sabra Healthcare REIT during the second quarter worth approximately $84,000. Finally, Compass Wealth Management LLC purchased a new position in Sabra Healthcare REIT during the third quarter worth approximately $89,000. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. National Bankshares set a $22.00 price target on Sabra Healthcare REIT in a report on Friday, October 17th. UBS Group assumed coverage on shares of Sabra Healthcare REIT in a research report on Tuesday, November 18th. They set a “neutral” rating and a $20.00 price objective for the company. Jefferies Financial Group reaffirmed a “buy” rating and set a $22.00 target price on shares of Sabra Healthcare REIT in a research note on Monday, December 15th. Truist Financial increased their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “hold” rating in a research note on Tuesday, January 20th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Thursday, January 22nd. Four research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Sabra Healthcare REIT currently has an average rating of “Hold” and a consensus price target of $21.11.

Sabra Healthcare REIT Price Performance

Sabra Healthcare REIT stock opened at $19.03 on Friday. The company’s 50 day simple moving average is $19.00 and its 200-day simple moving average is $18.72. The company has a debt-to-equity ratio of 0.92, a quick ratio of 5.19 and a current ratio of 5.19. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $19.97. The company has a market capitalization of $4.75 billion, a price-to-earnings ratio of 26.43, a price-to-earnings-growth ratio of 1.32 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.01. Sabra Healthcare REIT had a return on equity of 6.38% and a net margin of 23.50%.The company had revenue of $190.04 million for the quarter, compared to analysts’ expectations of $193.44 million. During the same period in the prior year, the firm earned $0.37 earnings per share. The firm’s revenue was up 6.7% compared to the same quarter last year. As a group, equities research analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 27th. Investors of record on Friday, February 13th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 13th. This represents a $1.20 annualized dividend and a yield of 6.3%. Sabra Healthcare REIT’s dividend payout ratio is presently 166.67%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.